HEADER HYDROLASE/HYDROLASE INHIBITOR 09-SEP-04 1XE5 TITLE STRUCTURE OF PLASMEPSIN II IN COMPLEX OF AN PEPSTATIN ANALOGUE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMEPSIN 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ASPARTIC HEMOGLOBINASE II, PFAPD; COMPND 5 EC: 3.4.23.39 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_COMMON: MALARIA PARASITE P. FALCIPARUM; SOURCE 4 ORGANISM_TAXID: 5833 KEYWDS HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR L.PRADE REVDAT 3 13-JUL-11 1XE5 1 VERSN REVDAT 2 24-FEB-09 1XE5 1 VERSN REVDAT 1 23-AUG-05 1XE5 0 JRNL AUTH L.PRADE JRNL TITL STRUCTURE OF PLASMEPSIN II IN COMPLEX OF AN PEPSTATIN JRNL TITL 2 ANALOGUE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 57.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 3 NUMBER OF REFLECTIONS : 41389 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2211 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.38 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.47 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2794 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2910 REMARK 3 BIN FREE R VALUE SET COUNT : 152 REMARK 3 BIN FREE R VALUE : 0.3400 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5214 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 98 REMARK 3 SOLVENT ATOMS : 232 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.44 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.10000 REMARK 3 B22 (A**2) : 1.10000 REMARK 3 B33 (A**2) : -1.66000 REMARK 3 B12 (A**2) : 0.55000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.265 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.233 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.170 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.538 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.942 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.905 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5448 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 4774 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7424 ; 1.366 ; 1.974 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11176 ; 0.792 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 656 ; 7.501 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 854 ; 0.085 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5992 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1074 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 986 ; 0.204 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 5728 ; 0.227 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 3279 ; 0.088 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 212 ; 0.147 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 13 ; 0.314 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 39 ; 0.234 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 12 ; 0.187 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3274 ; 0.685 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5332 ; 1.312 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2174 ; 1.457 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2092 ; 2.536 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 1XE5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 16-SEP-04. REMARK 100 THE RCSB ID CODE IS RCSB030259. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45644 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.390 REMARK 200 RESOLUTION RANGE LOW (A) : 119.520 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.09500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 68.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.85 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 32.78333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 65.56667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 65.56667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 32.78333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O VAL A 22 O GLN A 26 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD2 ASP B 235 O HIS B 161 3664 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 137 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP A 303 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP B 121 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 2 -37.87 179.40 REMARK 500 GLN A 12 51.71 38.10 REMARK 500 ASN A 13 -37.01 86.58 REMARK 500 ILE A 14 -93.39 -71.18 REMARK 500 GLN A 26 -113.66 66.98 REMARK 500 GLN A 27 93.05 89.75 REMARK 500 ALA A 38 24.37 -140.90 REMARK 500 ASP A 69 -73.24 -149.45 REMARK 500 SER A 135 65.98 34.49 REMARK 500 HIS A 161 -74.69 -32.87 REMARK 500 LYS A 163 -74.20 -62.40 REMARK 500 LEU A 191 -86.16 -140.32 REMARK 500 VAL A 201 -74.25 -125.34 REMARK 500 ASP A 235 72.18 -102.49 REMARK 500 ASN A 251 111.04 -31.45 REMARK 500 SER B 2 -39.02 151.52 REMARK 500 GLN B 26 -73.96 -59.02 REMARK 500 GLN B 27 76.34 52.67 REMARK 500 SER B 61 47.56 -101.51 REMARK 500 ASP B 69 -58.62 -128.46 REMARK 500 SER B 135 65.43 28.59 REMARK 500 ASN B 147 37.56 35.70 REMARK 500 HIS B 161 -75.48 -55.45 REMARK 500 LYS B 163 -58.95 -125.02 REMARK 500 LEU B 191 -87.00 -140.50 REMARK 500 ASN B 203 -30.01 172.72 REMARK 500 PHE B 241 -31.41 76.37 REMARK 500 PRO B 243 43.74 -86.41 REMARK 500 ASN B 251 109.69 -49.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: 5,5,5-TRIFLUORO-3-HYDROXY-4-[2-(5,5,5-TRIFLUORO-3- REMARK 630 HYDROXY-4-{3-METHYL-2-[3-METHYL-2-(3-METHYL-BUTYRYLAMINO)- REMARK 630 BUTYRYLAMINO]-BUTYRYLAMINO}-PENTANOYLAMINO)-PROPIONYLAMINO]- REMARK 630 PENTANOIC ACID METHYL ESTER REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 5FE A 500 REMARK 630 5FE B 500 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: IVA VAL VAL F3T ALA F3M REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 5FE A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 5FE B 500 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XDH RELATED DB: PDB REMARK 900 RELATED ID: 1XE6 RELATED DB: PDB REMARK 900 THE SAME PROTEIN AT 2.8 A DBREF 1XE5 A 1 329 UNP P46925 PLM2_PLAFA 125 453 DBREF 1XE5 B 1 329 UNP P46925 PLM2_PLAFA 125 453 SEQRES 1 A 329 SER SER ASN ASP ASN ILE GLU LEU VAL ASP PHE GLN ASN SEQRES 2 A 329 ILE MET PHE TYR GLY ASP ALA GLU VAL GLY ASP ASN GLN SEQRES 3 A 329 GLN PRO PHE THR PHE ILE LEU ASP THR GLY SER ALA ASN SEQRES 4 A 329 LEU TRP VAL PRO SER VAL LYS CYS THR THR ALA GLY CYS SEQRES 5 A 329 LEU THR LYS HIS LEU TYR ASP SER SER LYS SER ARG THR SEQRES 6 A 329 TYR GLU LYS ASP GLY THR LYS VAL GLU MET ASN TYR VAL SEQRES 7 A 329 SER GLY THR VAL SER GLY PHE PHE SER LYS ASP LEU VAL SEQRES 8 A 329 THR VAL GLY ASN LEU SER LEU PRO TYR LYS PHE ILE GLU SEQRES 9 A 329 VAL ILE ASP THR ASN GLY PHE GLU PRO THR TYR THR ALA SEQRES 10 A 329 SER THR PHE ASP GLY ILE LEU GLY LEU GLY TRP LYS ASP SEQRES 11 A 329 LEU SER ILE GLY SER VAL ASP PRO ILE VAL VAL GLU LEU SEQRES 12 A 329 LYS ASN GLN ASN LYS ILE GLU ASN ALA LEU PHE THR PHE SEQRES 13 A 329 TYR LEU PRO VAL HIS ASP LYS HIS THR GLY PHE LEU THR SEQRES 14 A 329 ILE GLY GLY ILE GLU GLU ARG PHE TYR GLU GLY PRO LEU SEQRES 15 A 329 THR TYR GLU LYS LEU ASN HIS ASP LEU TYR TRP GLN ILE SEQRES 16 A 329 THR LEU ASP ALA HIS VAL GLY ASN ILE MET LEU GLU LYS SEQRES 17 A 329 ALA ASN CYS ILE VAL ASP SER GLY THR SER ALA ILE THR SEQRES 18 A 329 VAL PRO THR ASP PHE LEU ASN LYS MET LEU GLN ASN LEU SEQRES 19 A 329 ASP VAL ILE LYS VAL PRO PHE LEU PRO PHE TYR VAL THR SEQRES 20 A 329 LEU CYS ASN ASN SER LYS LEU PRO THR PHE GLU PHE THR SEQRES 21 A 329 SER GLU ASN GLY LYS TYR THR LEU GLU PRO GLU TYR TYR SEQRES 22 A 329 LEU GLN HIS ILE GLU ASP VAL GLY PRO GLY LEU CYS MET SEQRES 23 A 329 LEU ASN ILE ILE GLY LEU ASP PHE PRO VAL PRO THR PHE SEQRES 24 A 329 ILE LEU GLY ASP PRO PHE MET ARG LYS TYR PHE THR VAL SEQRES 25 A 329 PHE ASP TYR ASP ASN HIS SER VAL GLY ILE ALA LEU ALA SEQRES 26 A 329 LYS LYS ASN LEU SEQRES 1 B 329 SER SER ASN ASP ASN ILE GLU LEU VAL ASP PHE GLN ASN SEQRES 2 B 329 ILE MET PHE TYR GLY ASP ALA GLU VAL GLY ASP ASN GLN SEQRES 3 B 329 GLN PRO PHE THR PHE ILE LEU ASP THR GLY SER ALA ASN SEQRES 4 B 329 LEU TRP VAL PRO SER VAL LYS CYS THR THR ALA GLY CYS SEQRES 5 B 329 LEU THR LYS HIS LEU TYR ASP SER SER LYS SER ARG THR SEQRES 6 B 329 TYR GLU LYS ASP GLY THR LYS VAL GLU MET ASN TYR VAL SEQRES 7 B 329 SER GLY THR VAL SER GLY PHE PHE SER LYS ASP LEU VAL SEQRES 8 B 329 THR VAL GLY ASN LEU SER LEU PRO TYR LYS PHE ILE GLU SEQRES 9 B 329 VAL ILE ASP THR ASN GLY PHE GLU PRO THR TYR THR ALA SEQRES 10 B 329 SER THR PHE ASP GLY ILE LEU GLY LEU GLY TRP LYS ASP SEQRES 11 B 329 LEU SER ILE GLY SER VAL ASP PRO ILE VAL VAL GLU LEU SEQRES 12 B 329 LYS ASN GLN ASN LYS ILE GLU ASN ALA LEU PHE THR PHE SEQRES 13 B 329 TYR LEU PRO VAL HIS ASP LYS HIS THR GLY PHE LEU THR SEQRES 14 B 329 ILE GLY GLY ILE GLU GLU ARG PHE TYR GLU GLY PRO LEU SEQRES 15 B 329 THR TYR GLU LYS LEU ASN HIS ASP LEU TYR TRP GLN ILE SEQRES 16 B 329 THR LEU ASP ALA HIS VAL GLY ASN ILE MET LEU GLU LYS SEQRES 17 B 329 ALA ASN CYS ILE VAL ASP SER GLY THR SER ALA ILE THR SEQRES 18 B 329 VAL PRO THR ASP PHE LEU ASN LYS MET LEU GLN ASN LEU SEQRES 19 B 329 ASP VAL ILE LYS VAL PRO PHE LEU PRO PHE TYR VAL THR SEQRES 20 B 329 LEU CYS ASN ASN SER LYS LEU PRO THR PHE GLU PHE THR SEQRES 21 B 329 SER GLU ASN GLY LYS TYR THR LEU GLU PRO GLU TYR TYR SEQRES 22 B 329 LEU GLN HIS ILE GLU ASP VAL GLY PRO GLY LEU CYS MET SEQRES 23 B 329 LEU ASN ILE ILE GLY LEU ASP PHE PRO VAL PRO THR PHE SEQRES 24 B 329 ILE LEU GLY ASP PRO PHE MET ARG LYS TYR PHE THR VAL SEQRES 25 B 329 PHE ASP TYR ASP ASN HIS SER VAL GLY ILE ALA LEU ALA SEQRES 26 B 329 LYS LYS ASN LEU HET 5FE A 500 49 HET 5FE B 500 49 HETNAM 5FE 5,5,5-TRIFLUORO-3-HYDROXY-4-[2-(5,5,5-TRIFLUORO-3- HETNAM 2 5FE HYDROXY-4-{3-METHYL-2-[3-METHYL-2-(3-METHYL- HETNAM 3 5FE BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- HETNAM 4 5FE PENTANOYLAMINO)-PROPIONYLAMINO]-PENTANOIC ACID METHYL HETNAM 5 5FE ESTER FORMUL 3 5FE 2(C29 H47 F6 N5 O9) FORMUL 5 HOH *232(H2 O) HELIX 1 1 THR A 49 LYS A 55 5 7 HELIX 2 2 ASP A 59 SER A 63 5 5 HELIX 3 3 THR A 108 GLU A 112 5 5 HELIX 4 4 PRO A 113 SER A 118 1 6 HELIX 5 5 TRP A 128 SER A 132 5 5 HELIX 6 6 PRO A 138 GLN A 146 1 9 HELIX 7 7 GLU A 174 ARG A 176 5 3 HELIX 8 8 PRO A 223 LEU A 231 1 9 HELIX 9 9 GLU A 269 TYR A 273 1 5 HELIX 10 10 GLY A 302 LYS A 308 1 7 HELIX 11 11 GLY B 51 LYS B 55 5 5 HELIX 12 12 ASP B 59 SER B 63 5 5 HELIX 13 13 THR B 108 GLU B 112 5 5 HELIX 14 14 PRO B 113 SER B 118 1 6 HELIX 15 15 TRP B 128 SER B 132 5 5 HELIX 16 16 PRO B 138 GLN B 146 1 9 HELIX 17 17 GLU B 174 ARG B 176 5 3 HELIX 18 18 PRO B 223 ASN B 233 1 11 HELIX 19 19 GLU B 269 LEU B 274 1 6 HELIX 20 20 GLY B 302 LYS B 308 1 7 SSBOND 1 CYS A 47 CYS A 52 1555 1555 2.08 SSBOND 2 CYS A 249 CYS A 285 1555 1555 2.09 SSBOND 3 CYS B 47 CYS B 52 1555 1555 2.06 SSBOND 4 CYS B 249 CYS B 285 1555 1555 2.06 CISPEP 1 GLU A 112 PRO A 113 0 7.27 CISPEP 2 GLU B 112 PRO B 113 0 7.94 SITE 1 AC1 15 ASP A 34 GLY A 36 SER A 37 ASN A 76 SITE 2 AC1 15 TYR A 77 VAL A 78 SER A 79 TYR A 192 SITE 3 AC1 15 ASP A 214 GLY A 216 THR A 217 SER A 218 SITE 4 AC1 15 ILE A 290 HOH A 403 PHE B 241 SITE 1 AC2 18 PHE A 241 LEU A 242 ASP B 34 GLY B 36 SITE 2 AC2 18 ASN B 76 TYR B 77 VAL B 78 SER B 79 SITE 3 AC2 18 ILE B 123 LEU B 131 TYR B 192 ASP B 214 SITE 4 AC2 18 GLY B 216 THR B 217 SER B 218 ALA B 219 SITE 5 AC2 18 ILE B 290 ILE B 300 CRYST1 141.650 141.650 98.350 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007060 0.004076 0.000000 0.00000 SCALE2 0.000000 0.008152 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010168 0.00000